The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth

February 2nd, 2012 by Dividend Yield
+2.86%
Upside
27.81
Market
28.61
Trefis
PFE: Pfizer logo
PFE
Pfizer

This article was submitted by Dividend Yield using our Trefis Contributors tool

Growth is a wonderful instrument for wealth building. I screened the healthcare sector by stocks with the highest earnings per share growth for the next five years (at least 5 percent yearly). In addition, the company should pay today more than three percent in dividends. 10 stocks fulfilled my criteria of which six yielding above 4 percent. Nine stocks have a buy recommendation and one a strong buy rating.

Here are my favorite stocks:

1. GlaxoSmithKline (GSK) has a market capitalization of $114.39 billion. The company employs 96,461 people, generates revenues of $44,734.36 million and has a net income of $2,919.58 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,615.36 million. Because of these figures, the EBITDA margin is 19.26 percent (operating margin 13.32 percent and the net profit margin finally 6.53 percent).

Relevant Articles
  1. What Factors Will Drive Pfizer’s Q1 Performance?
  2. After A 30% Fall In A Year Is Pfizer Stock A Better Pick Over Merck?
  3. Should You Pick Pfizer Stock At $30 After A 30% Fall In A Year?
  4. Should You Pick Pfizer Stock At $30?
  5. Down 25% In A Year Will Pfizer Stock Rebound To Its Pre-Inflation Shock Level?
  6. Will Pfizer Stock See Higher Levels Post Q1 Earnings?

Twelve trailing months earnings per share reached a value of $2.05. Last fiscal year, the company paid $2.05 in form of dividends to shareholders.

Here are the price ratios of the company: The P/E ratio is 22.07, Price/Sales 2.50 and Price/Book ratio 8.10. Dividend Yield: 4.95 percent. The beta ratio is 0.61.

2. Johnson & Johnson (JNJ) has a market capitalization of $179.39 billion. The company employs 117,000 people, generates revenues of $65,030.00 million and has a net income of $9,672.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $12,841.00 million. Because of these figures, the EBITDA margin is 19.75 percent (operating margin 19.01 percent and the net profit margin finally 14.87 percent).

Twelve trailing months earnings per share reached a value of $3.48. Last fiscal year, the company paid $2.25 in form of dividends to shareholders.

Here are the price ratios of the company: The P/E ratio is 18.86, Price/Sales 2.77 and Price/Book ratio is not calculable. Dividend Yield: 3.46 percent. The beta ratio is 0.55.

3. Abbott Laboratories (ABT) has a market capitalization of $84.53 billion. The company employs 90,000 people, generates revenues of $38,851.00 million and has a net income of $4,729.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $5,615.00 million. Because of these figures, the EBITDA margin is 14.45 percent (operating margin 14.45 percent and the net profit margin finally 12.17 percent).

Twelve trailing months earnings per share reached a value of $3.00. Last fiscal year, the company paid $1.92 in form of dividends to shareholders.

Here are the price ratios of the company: The P/E ratio is 18.06, Price/Sales 2.17 and Price/Book ratio is not calculable. Dividend Yield: 3.55 percent. The beta ratio is 0.29.

Take a closer look at the full table of best yielding healthcare growth stocks. The average price to earnings ratio (P/E ratio) amounts to 16.35. The dividend yield has a value of 3.71 percent. Price to book ratio is 2.77 and price to sales ratio 2.06. The operating margin amounts to 14.08 percent.

Related stock ticker symbols: